Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals is seeking a Senior Scientist, Radiochemistry to oversee the radiolabeling and conjugation of antibodies and antibody fragments with radiometals. This role supports the international roll-out of a prostate cancer imaging agent and contributes to translational research in cancer theranostics and therapeutic applications. The RSO will ensure compliance with radiation safety regulations and maintain a strong safety culture.
Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals Limited